相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Cancer Stem Cells: Promises and Challenges
Jan Dominik Kuhlmann et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Inhibition of invasion by glycogen synthase kinase-3 beta inhibitors through dysregulation of actin re-organisation via down-regulation of WAVE2
Yuki Yoshino et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Combining targeted therapeutics in the era of precision medicine
D. Papadatos-Pastos et al.
BRITISH JOURNAL OF CANCER (2015)
GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway
Xu Ying et al.
CANCER CELL INTERNATIONAL (2015)
Prodding the Beast: Assessing the Impact of Treatment-Induced Metastasis
John M. L. Ebos
CANCER RESEARCH (2015)
Intratumoral Heterogeneity: From Diversity Comes Resistance
Ariel Pribluda et al.
CLINICAL CANCER RESEARCH (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
A. Borah et al.
ONCOGENESIS (2015)
Glycogen Synthase Kinase 3β Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway
Yuri Chikano et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
P. Ramos et al.
ONCOGENE (2015)
Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells
Yuki Yoshino et al.
SCIENTIFIC REPORTS (2015)
Tumorigenesis: it takes a village
Doris P. Tabassum et al.
NATURE REVIEWS CANCER (2015)
Inhibition of GSK-3 Induces Differentiation and Impaired Glucose Metabolism in Renal Cancer
Krishnendu Pal et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease
D. R. Cook et al.
ONCOGENE (2014)
Invading one step at a time: the role of invadopodia in tumor metastasis
H. Paz et al.
ONCOGENE (2014)
GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells
Jing Zeng et al.
PLOS ONE (2014)
Glycogen Synthase Kinase 3 Protein Kinase Activity Is Frequently Elevated in Human Non-Small Cell Lung Carcinoma and Supports Tumour Cell Proliferation
Emma E. Vincent et al.
PLOS ONE (2014)
Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma
Eleanor Y. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth
Jan Kroon et al.
ONCOTARGET (2014)
GSK-3 as potential target for therapeutic irvention in cancer
James A. McCubrey et al.
ONCOTARGET (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
Activator or inhibitor? GSK-3 as a new drug target
Fumi Takahashi-Yanaga
BIOCHEMICAL PHARMACOLOGY (2013)
Glycogen synthase kinase 3 inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling
Ilya V. Pyko et al.
CARCINOGENESIS (2013)
Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
Emanuela Grassilli et al.
CLINICAL CANCER RESEARCH (2013)
Glycogen Synthase Kinase 3β Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer
Yan Yin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis
Hemant K. Bid et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Tumor metastasis: moving new biological insights into the clinic
Liling Wan et al.
NATURE MEDICINE (2013)
Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
Ayako Kitano et al.
PLOS ONE (2013)
Unravelling cancer stem cell potential
Benjamin Beck et al.
NATURE REVIEWS CANCER (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
GSK-3 inhibition in vitro and in vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC)
Hisashi Kawazoe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
The Dark Side of E2F1: In Transit beyond Apoptosis
David Engelmann et al.
CANCER RESEARCH (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer
R. Siobhan Darrington et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
Takeo Shimasaki et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Glycogen Synthase Kinase-3β, NF-κB Signaling, and Tumorigenesis of Human Osteosarcoma
Qing-Lian Tang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Glycogen synthase kinase-3 (GSK-3) inhibition induces apoptosis in leukemic cells through mitochondria-dependent pathway
Mohammad Reza Mirlashari et al.
LEUKEMIA RESEARCH (2012)
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani et al.
NATURE BIOTECHNOLOGY (2012)
Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
Stephanie Alexander et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Indirubins Decrease Glioma Invasion by Blocking Migratory Phenotypes in Both the Tumor and Stromal Endothelial Cell Compartments
Shante P. Williams et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Cancer Stem Cells and Chemosensitivity
Marcello Maugeri-Sacca et al.
CLINICAL CANCER RESEARCH (2011)
Suppression of Glycogen Synthase Kinase 3 Activity Reduces Tumor Growth of Prostate Cancer In vivo
Qing Zhu et al.
PROSTATE (2011)
Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells
Fu-Yue Zeng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Glycogen Synthase Kinase-3β: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer
Sei Naito et al.
CLINICAL CANCER RESEARCH (2010)
Targeting the RB-pathway in Cancer Therapy
Erik S. Knudsen et al.
CLINICAL CANCER RESEARCH (2010)
Glycogen synthase kinases-3β controls differentiation of malignant glioma cells
Yan Li et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)
Eleonore Beurel et al.
TRENDS IN IMMUNOLOGY (2010)
An Emerging Strategy for Cancer Treatment Targeting Aberrant Glycogen Synthase Kinase 3β
Katsuyoshi Miyashita et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
V. Bilim et al.
BRITISH JOURNAL OF CANCER (2009)
EMT, the cytoskeleton, and cancer cell invasion
Mahmut Yilmaz et al.
CANCER AND METASTASIS REVIEWS (2009)
Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
Jia Luo
CANCER LETTERS (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Potential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma
Katsuyoshi Miyashita et al.
CLINICAL CANCER RESEARCH (2009)
Deregulated GSK3β Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase
Wei Mai et al.
CLINICAL CANCER RESEARCH (2009)
Glycogen synthase kinase 3 in the world of cell migration
Tong Sun et al.
DEVELOPMENT GROWTH & DIFFERENTIATION (2009)
GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
Serdar Korur et al.
PLOS ONE (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Maintenance of constitutive IκB kinase activity by glycogen synthase kinase-3α/β in pancreatic cancer
Willie Wilson et al.
CANCER RESEARCH (2008)
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-κB, and glucose regulation
Svetlana Kotliarova et al.
CANCER RESEARCH (2008)
Lamellipodia and filopodia in metastasis and invasion
Laura M. Machesky
FEBS LETTERS (2008)
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
Zhong Wang et al.
NATURE (2008)
Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3
Michal O. Nowicki et al.
NEURO-ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Inhibition of GSK-3β activity attenuates proliferation of human colon cancer cells in rodents
Abbas Shakoori et al.
CANCER SCIENCE (2007)
Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines
Bradley W. Doble et al.
DEVELOPMENTAL CELL (2007)
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Richard S. Jope et al.
NEUROCHEMICAL RESEARCH (2007)
Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells
Qi Cao et al.
CELL RESEARCH (2006)
Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation
JJ Trowbridge et al.
NATURE MEDICINE (2006)
Detection of active fraction of glycogen synthase kinase 3 beta in cancer cells by nonradioisotopic in vitro kinase assay
Wei Mai et al.
ONCOLOGY (2006)
Pharmacologic modulation of glycogen synthase kinase-3β promotes p53-dependent apoptosis through a direct bax-mediated mitochondrial pathway in colorectal cancer cells
J Tan et al.
CANCER RESEARCH (2005)
Deregulated GSK3β activity in colorectal cancer:: Its association with tumor cell survival and proliferation
A Shakoori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells
AV Ougolkov et al.
CANCER RESEARCH (2005)
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor
N Sato et al.
NATURE MEDICINE (2004)
Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth
M Mazor et al.
ONCOGENE (2004)
Tumour-cell invasion and migration: Diversity and escape mechanisms
P Friedl et al.
NATURE REVIEWS CANCER (2003)
分享论文
